In Brief: EPA pharmaceutical effluents
This article was originally published in The Tan Sheet
Executive Summary
EPA pharmaceutical effluents: Environmental Protection Agency Aug. 8 Federal Register notice announces availability of follow-on documents to May 2, 1995 EPA Clean Water Act effluent limitations guidelines, new source performance standards for the introduction of pharmaceutical manufacturing source pollutants into public water treatment works, new analyses of old and newly acquired data, and suggested modifications to the 1995 proposal. Comments are due by Sept. 22 to EPA's Frank Hund, Engineering & Analysis Division, 401 M St., S.W., Washington, D.C. 20460...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning